**Abstract**

Empathy, a high-level cognitive process, is believed to exist exclusively in humans; however, recent evidence has demonstrated empathy-like behaviors in rodents. The rodent models provide experimental platforms to investigate the neural basis for empathy and help elucidating the mechanisms underlying pathological conditions, such as autism spectrum disorders (ASDs). People with ASD have social impairments and often lack the ability to fully understand emotions in others, however, the neural substrates for the deficits remain largely unknown. In this study, we developed a fear observational system in which a mouse (observer) exhibits freezing behavior, a form of fear responses, through observation of another freezing mouse (demonstrator) that receives repetitive electrical foot shocks. We found that observers showed higher freezing responses when they had received a priming foot shock, suggesting that empathy-based behavior of mice is enhanced by a previous similar experience. Next, we investigated the relationship between neuronal populations that were active during the direct shock experience and observation of the other's shocks in neocortical regions involved in pain coding. To detect neural activities with cellular resolution, we used a biochemical technique called catFISH. The neuronal populations that were active during the priming shock were significantly overlapped with those engaged in the fear observation, indicating that neural networks involved in firsthand and vicarious experiences are shared at the single-cell level. We then examined empathetic behaviors in ASD model mice. The ASD model was produced by intraperitoneal injection of poly(I:C) into pregnant females. In ASD model mice, observational fear was not enhanced by a priming foot shook, and this behavioral deficit was rescued by sub-chronic injection of oxytocin. Moreover, the degree of neural overlap was significantly low in ASD model mice. These findings offer insight into our understanding of the neural mechanisms of empathy and the development of therapeutic treatment of ASD.
